Telescope Innovations Corp. (TELIF)
- Newsfile
Telescope Innovations and Standard Lithium Demonstrate Low-Temperature, High-Purity Production of Lithium Sulfide for Solid-State Batteries
Vancouver, British Columbia--(Newsfile Corp. - August 28, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope Innovations" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, announces the successful outcome of a research collaboration with Standard Lithium Ltd. (TSXV: SLI) (NYSE American: SLI) ("Standard Lithium").Over the past year, Telescope Innovations and Standard Lithium have worked toget
- Newsfile
Telescope Innovations and Pfizer Sign Master Collaborative Research Agreement
Funding from and collaboration with Pfizer could facilitate Telescope's growth and R&D advancement Vancouver, British Columbia--(Newsfile Corp. - July 31, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of enabling technologies and services for the global pharmaceutical and chemical industries, is pleased to announce the execution of a master collaborative research agreement (the "Agreement") with Pfizer Inc. ("Pfizer"). Under the multi-
- Newsfile
Telescope Innovations Receives CICE Funding to Pilot Lithium Refinement Technology
Vancouver, British Columbia--(Newsfile Corp. - July 22, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, has been awarded $400,273 in early-stage funding from the B.C. Centre for Innovation and Clean Energy ("CICE"). This non-dilutive investment will support Telescope's piloting of its proprietary Recrystallization Refinement Technology ("ReCRFT™"
